1. Home
  2. BCAB vs FGL Comparison

BCAB vs FGL Comparison

Compare BCAB & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • FGL
  • Stock Information
  • Founded
  • BCAB 2007
  • FGL 2021
  • Country
  • BCAB United States
  • FGL Malaysia
  • Employees
  • BCAB N/A
  • FGL N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • FGL
  • Sector
  • BCAB Health Care
  • FGL
  • Exchange
  • BCAB Nasdaq
  • FGL NYSE
  • Market Cap
  • BCAB 27.0M
  • FGL 24.0M
  • IPO Year
  • BCAB 2020
  • FGL 2024
  • Fundamental
  • Price
  • BCAB $0.31
  • FGL $1.40
  • Analyst Decision
  • BCAB Buy
  • FGL
  • Analyst Count
  • BCAB 2
  • FGL 0
  • Target Price
  • BCAB $5.00
  • FGL N/A
  • AVG Volume (30 Days)
  • BCAB 1.1M
  • FGL 104.4K
  • Earning Date
  • BCAB 03-25-2025
  • FGL 12-17-2024
  • Dividend Yield
  • BCAB N/A
  • FGL N/A
  • EPS Growth
  • BCAB N/A
  • FGL 45.69
  • EPS
  • BCAB N/A
  • FGL 0.04
  • Revenue
  • BCAB $11,000,000.00
  • FGL $23,268,519.00
  • Revenue This Year
  • BCAB N/A
  • FGL N/A
  • Revenue Next Year
  • BCAB N/A
  • FGL N/A
  • P/E Ratio
  • BCAB N/A
  • FGL $36.30
  • Revenue Growth
  • BCAB N/A
  • FGL 336.06
  • 52 Week Low
  • BCAB $0.24
  • FGL $1.25
  • 52 Week High
  • BCAB $4.02
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 32.63
  • FGL N/A
  • Support Level
  • BCAB $0.24
  • FGL N/A
  • Resistance Level
  • BCAB $0.36
  • FGL N/A
  • Average True Range (ATR)
  • BCAB 0.04
  • FGL 0.00
  • MACD
  • BCAB 0.01
  • FGL 0.00
  • Stochastic Oscillator
  • BCAB 29.39
  • FGL 0.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About FGL FOUNDER GROUP LTD

Founder Group Ltd acts as an end-to-end Engineering, Procurement, Construction, and Commissioning solutions provider for solar PV facilities in Malaysia. The segments of the company are large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects of the company are utility-scale solar PV power plants with installed generating capacity of 1 MWac or more, and C&I projects of the company are smaller-scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their consumption at factories, warehouses, and commercial stores. The company derives its revenue from Malaysia.

Share on Social Networks: